SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-14-046060
Filing Date
2014-06-16
Accepted
2014-06-16 06:02:41
Documents
5
Effectiveness Date
2014-06-16

Document Format Files

Seq Description Document Type Size
1 DEFA14A a14-15473_1defa14a.htm DEFA14A 58052
2 GRAPHIC g154731bci001.jpg GRAPHIC 5230
3 GRAPHIC g154731bci002.jpg GRAPHIC 2234
4 GRAPHIC g154731bci003.jpg GRAPHIC 20483
5 GRAPHIC g154731bci004.gif GRAPHIC 4486
  Complete submission text file 0001104659-14-046060.txt   104409
Mailing Address 1040 SPRING ST SILVER SPRING MD 20910
Business Address 1040 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Filer) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-26301 | Film No.: 14921393
SIC: 2834 Pharmaceutical Preparations